Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Israel Over the Counter (OTC) Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Product Type (Cough, Cold and Flu; Vitamins, Mineral & Supplements (VMS); Analgesics; Gastrointestinal Products; Dermatology Products; Others)
5.2.2. By Route of Administration (Oral, Topical, Parenteral, Others)
5.2.3. By Dosage Form (Tablets, Capsules, Liquids & Solution, Creams/Lotions/Ointments, Others)
5.2.4. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
5.2.5. By Region
5.2.6. By Company (2022)
5.3. Product Market Map
5.3.1. By Product Type
5.3.2. By Route of Administration
5.3.3. By Dosage Form
5.3.4. By Distribution Channel
6. Israel Cough, Cold and Flu Over the Counter (OTC) Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Route of Administration
6.2.2. By Dosage Form
6.2.3. By Distribution Channel
7. Israel Vitamins, Mineral & Supplements (VMS) Over the Counter (OTC) Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Route of Administration
7.2.2. By Dosage Form
7.2.3. By Distribution Channel
8. Israel Analgesics Over the Counter (OTC) Drugs Market Outlook
8.1.1. Market Size & Forecast
8.1.1.1. By Value & Volume
8.1.2. Market Share & Forecast
8.1.2.1. By Route of Administration
8.1.2.2. By Dosage Form
8.1.2.3. By Distribution Channel
9. Israel Gastrointestinal Over the Counter (OTC) Drugs Market Outlook
9.1.1. Market Size & Forecast
9.1.1.1. By Value & Volume
9.1.2. Market Share & Forecast
9.1.2.1. By Route of Administration
9.1.2.2. By Dosage Form
9.1.2.3. By Distribution Channel
10. Israel Dermatology Over the Counter (OTC) Drugs Market Outlook
10.1.1. Market Size & Forecast
10.1.1.1. By Value & Volume
10.1.2. Market Share & Forecast
10.1.2.1. By Route of Administration
10.1.2.2. By Dosage Form
10.1.2.3. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.1.1. Accessibility and Availability of OTC drugs
11.1.2. Increasing prevalence of Seasonal Flu
11.1.3. Increasing trend of Self Medication
11.2. Challenges
11.2.1. Substance Abuse
11.2.2. Adverse Reaction
11.2.3. Toxicity Overdose
12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Policy & Regulatory Landscape
14. Porters Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Israel Economic Profile
16. Competitive Landscape
16.1. Business Overview
16.2. Product Offerings
16.3. Recent Developments
16.4. Financials (As Reported)
16.5. Key Personnel
16.6. SWOT Analysis
16.6.1. Teva Pharmaceutical Industries Ltd.
16.6.2. GlaxoSmithKline plc
16.6.3. AstraZeneca Israel
16.6.4. Bayer Israel Ltd.
16.6.5. Pfizer Inc.
16.6.6. Johnson & Johnson
16.6.7. Novartis Israel Ltd.
16.6.8. Taro Pharmaceutical Industries Ltd.
16.6.9. Neopharm Israel
16.6.10. Sol-Gel Technologies Ltd.
17. Strategic Recommendations
18. About Us & Disclaimer